Bahasa

   Home    Contact

A. ORGANISATIONS

1. International League of Association for Rheumatology (www.ilar.org)




2. Lupus Foundation of America, Inc (www.lupus.org)

  

3. American College of Rheumatology (www.rheumatology.org)


4. Australian Rheumatology of Association (www.rheumatology.org.au)

  
 

B. JOURNALS

1. Lupus, An International Journal (www.lupus-journal.com)

  

2. Rheumatology Journal, formerly the British Journal of Rheumatology
    (http://rheumatology.oupjournals.org)

  

3. Journal of Rheumatology (http://www.jrheum.com)

C. OTHERS

1. Lupus Site (www.uklupus.co.uk/lupdat.html)


 

  Email This Page   Print This Page
 
NEWS & EVENTS

LupusArthritisIndonesia.org - Indonesian Lupus & Arthritis Forum

16.11.2005
MabThera – a unique approach providing lasting benefits for patients with rheumatoid arthritis

Comprehensive long-term clinical success achieved in difficult-to-treat patients following just two administrations, two weeks apart
 › more

 
 
LupusArthritisIndonesia.org - Indonesian Lupus & Arthritis Forum

06.09.2005
Roche files first rheumatoid arthritis indication for MabThera in Europe

MabThera: a medicine used to treat non-Hodgkin's lymphoma

MabThera delivers significant and sustained relief from symptoms in patients with difficult-to-treat rheumatoid arthritis.
› more
 
LupusArthritisIndonesia.org - Indonesian Lupus & Arthritis Forum

06.04.2005
MabThera significantly improves symptoms in patients with rheumatoid arthritis who inadequately responded to anti-TNFα therapies

Third large randomised trial to evaluate efficacy and safety of MabThera in RA

Roche, Genentech and Biogen Idec announced today that REFLEX1, a pivotal Phase III study of MabThera (rituximab), successfully met its primary endpoint in the group of patients with the most difficult-to-treat rheumatoid arthritis (RA).
 › more

 

Website Partner


Supported by PT Roche Indonesia